Raymond James Financial Services Advisors Inc. Purchases 4,330 Shares of MetLife, Inc. (NYSE:MET)

Raymond James Financial Services Advisors Inc. raised its position in MetLife, Inc. (NYSE:METFree Report) by 1.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 335,598 shares of the financial services provider’s stock after buying an additional 4,330 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in MetLife were worth $22,193,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in MET. Norges Bank bought a new position in MetLife in the 4th quarter worth about $444,205,000. Pzena Investment Management LLC lifted its holdings in MetLife by 118.1% in the 3rd quarter. Pzena Investment Management LLC now owns 10,108,992 shares of the financial services provider’s stock worth $635,957,000 after buying an additional 5,474,449 shares during the period. Moneta Group Investment Advisors LLC purchased a new stake in MetLife in the 4th quarter worth approximately $234,761,000. DekaBank Deutsche Girozentrale lifted its holdings in MetLife by 806.2% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 1,607,195 shares of the financial services provider’s stock worth $100,152,000 after buying an additional 1,429,840 shares during the period. Finally, Ensign Peak Advisors Inc lifted its holdings in MetLife by 309.7% in the 1st quarter. Ensign Peak Advisors Inc now owns 1,364,265 shares of the financial services provider’s stock worth $95,881,000 after buying an additional 1,031,277 shares during the period. 89.81% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

MET has been the subject of several research analyst reports. UBS Group dropped their price objective on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a report on Monday, February 5th. Keefe, Bruyette & Woods lowered their target price on MetLife from $79.00 to $77.00 and set an “outperform” rating for the company in a research note on Thursday, December 7th. Wells Fargo & Company lowered their target price on MetLife from $85.00 to $83.00 and set an “overweight” rating for the company in a research note on Tuesday, February 6th. Finally, The Goldman Sachs Group raised MetLife from a “neutral” rating to a “buy” rating and raised their price objective for the company from $70.00 to $80.00 in a research report on Monday, January 8th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, MetLife currently has an average rating of “Moderate Buy” and a consensus target price of $77.23.

Check Out Our Latest Report on MetLife

Insiders Place Their Bets

In other MetLife news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the sale, the insider now directly owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the sale, the insider now directly owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the transaction, the executive vice president now directly owns 57,768 shares in the company, valued at approximately $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by insiders.

MetLife Price Performance

NYSE MET opened at $74.11 on Friday. The company has a market capitalization of $53.58 billion, a PE ratio of 40.50, a price-to-earnings-growth ratio of 0.55 and a beta of 1.03. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.16 and a current ratio of 0.16. The business’s fifty day moving average is $69.88 and its 200 day moving average is $65.88. MetLife, Inc. has a fifty-two week low of $48.95 and a fifty-two week high of $74.39.

MetLife (NYSE:METGet Free Report) last announced its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing the consensus estimate of $1.95 by ($0.02). MetLife had a net margin of 2.36% and a return on equity of 19.48%. The business had revenue of $18.72 billion during the quarter, compared to analysts’ expectations of $18.07 billion. Sell-side analysts predict that MetLife, Inc. will post 8.81 earnings per share for the current year.

MetLife Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 14th. Stockholders of record on Tuesday, February 6th were issued a $0.52 dividend. The ex-dividend date was Monday, February 5th. This represents a $2.08 annualized dividend and a dividend yield of 2.81%. MetLife’s dividend payout ratio (DPR) is 113.66%.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.